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Summary: The purpose of the present study was:
1) to evaluate which of the four iron status markers (serum iron, serum transferrin, serum transferrin saturation,
serum ferritin) displayed the highest discriminatory potential in the distinction between homozygous patients with
hereditary haemochromatosis and heterozygous relatives,
2) to suggest optimum cut-off values for these iron status markers, and
3) to demonstrate how these cut-off values change if the expected utility from a correct diagnosis is incorporated
into the analysis.
The patients and relatives were found by a nation-wide epidemiological survey. The study population consisted of 162
patients with clinically overt hereditary haemochromatosis and 84 asymptomatic heterozygous relatives. The statistical
evaluation was performed using receiver operating characteristic (ROC) curve analysis. The diagnostic power of the
iron markers is expressed as the area under the ROC curve. The optimum cut-off value is at the point where the slope
of the ROC curve is equal to one. Changes in the optimum cut-off value at varying expected utility from a correct
classification was estimated by changing the scaling of the ROC diagram. Serum iron and serum transferrin had the
smallest area under the ROC curve, and were both unsuitable as discriminators. Near complete discrimination was
obtained with serum transferrin saturation and serum ferritin concentrations, displaying the largest area under the ROC
curve (0.991 and 0.998). The optimum threshold value for transferrin saturation was 61%, and for serum ferritin con-
centration 800 μg/l. The transferrin saturation level reflects the presence of the haemochromatosis allele, whereas the
serum ferritin concentration indicates the degree of iron overload. Changes in the optimum cut-off value from varying
expected utility implicated the importance of incorporating this discriminator.
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Subjects and Methods
The material consisted of samples from 162 Danish patients (126
men, 36 women, median age 55 years, range 29-81) with heredi-
tary haemochromatosis, found by a nation-wide epidemiological
survey (2, 6). All patients had clinically overt disease and were
considered to be homozygous for the haemochromatosis allele. The
diagnostic criteria and the selection of the patients have been de-
scribed previously (2, 6). Pedigree studies were performed in 32 of
the patients (probands) with haemochromatosis, HLA-typing being
employed in 21 families (7). Altogether, 84 heterozygous subjects
(39 men, 45 women) were identified and included in the study.
Blood samples were obtained in the fasting state in the morning.
Serum iron was analyzed by spectrophotometry on a centrifugal
analyser (Cobas Bio®, F. Hoffmann-La Roche AG, CH-4002 Ba-
sel) using guanidinium ferrozine as chromogen, following release
from transferrin with HCI and subsequent reduction with ascorbic
acid (Unimate 7 Iron®, Roche Diagnostic Systems, F. Hoffinann-
La Roche AG, CH-4002 Basel). Samples were analyzed in dupli-
cate. The overall analytical coefficient of variation was 3.1%.
Serum transferrin (IFCC relative molecular mass Mr 74 000) was
measured by immunoturbidimetry on a centrifugal analyser (Cobas
Bio®, F. Hoffinann-La Roche AG, CH-4002 Basel) using the Uni-
mate 3 Transferrin® (Roche Diagnostic Systems, F. Hoffmann-La
Roche AG, CIJ-4002 Basel). Calibration was performed with the
human protein standard CRM 470. Samples were analysed in du-
plicate. The overall analytical coefficient of variation was 3.3%.
The transferrin saturation in percent was calculated as: serum iron,
μτηοΐ/ΐ X 100/serum transferrin, μιηοΐ/l Χ 2.
Serum ferritin was measured with a two-site immunoradiometric
assay, employing specially prepared paper discs as the solid phase
(Phadebas Ferritin FRIST®, Pharmacia Diagnostics AB, S-75182
Uppsala) and described in detail elsewhere (8). Samples were run
in duplicate. The overall analytical coefficient of variation was
8.8%. Calibration of the kit using the WHO Human Liver Ferritin
International Standard 80/602, showed that a Phadebas value of 11
μg/l corresponded to a WHO value of 15 μg/l (9).
Statistical methods
In order to obtain an estimate of the diagnostic power of the four
variables, ROC curves were constructed. A ROC curve is a plot of
the true positive fraction, TPF, (n (true positive)/n (all diseased
subjects)), as a function of the false positive fraction, FPF, (n (false
positive)/n (all non-diseased subjects)), when the cut-off value runs
from -co to +00 (10). The ROC curves were fitted by the equa-
tion (11)
TPF = R X FPF1/E + (1 - R) X (1 - (1 - FPF)E)
where E, which is > 1 for any test of practical value, determines
the height of the vault of the curve, and R the skewness of the
curve (0 ̂  R ̂  1). The E and R parameters were estimated by
non-linear regression. A least square lost function was used. The
minimization algorithm was initiated by a Rosenbrock algorithm
(to avoid local minima), followed by a quasi-Afeivro;? minimization
algorithm (12). The area under the ROC curve was subsequently
calculated as
Area = E/(E -I- I)
and was taken as an estimate of accuracy.
The optimum cut-off value is situated at the point where the slope
of the ROC curve is equal to one. To include the expected utility
from a correct classification, the axes were scaled by the fre-
quencies of the two conditions (homozygosity and heterozygosity)
and the expected utility. The ordinate axis was multiplied by the
frequency of homozygous subjects and by the benefit a homozy-
gous patient would miss if he was misclassified, i.e., false nega-
tive. The abscissa axis was multiplied by the frequency of hetero-
zygous subjects and by the cost of examining a non-diseased per-
son (13). The cut-off values were calculated for various benefit/
cost ratios.
Results
Iron status markers in homozygo patients and hetero-
zygous subjects are shown in table L Homozygotes had
significantly higher serum iron concentration, lower se-
rum transferrin concentration, higher transferrin satura-
tion, and higher serum ferritin concentration than hetero-
zygotes.
The ROC curves for the four iron status markers are
depicted in figure 1, and the area under the ROC curve,
and optimum discriminatory values for each variable are
displayed in table 2.
It is evident from the curve that serum iron concentra-
tion and serum transferrin concentration had the lowest
discriminatory potential between homozygous and het-
Tab. 1 Iron status markers (median and range) in homozygous





































*) Mann-Whitney test: ρ < 0.0001
False positive fraction
Fig. 1 ^Exponentially fitted receiver operating characteristic
(ROC) curves for iron status markers in hereditary haemochro^
matosis.
x S-iron * Transferrin saturation
+ S-transferrin a »S-ferritin
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Tab. 2 Optimum cut-off values for iron status markers in heredi-
tary haemochromatosis at various levels of expected utility. The
diagnostic power of the four markers are expressed as the area
under the ROC curve. B denotes the benefit a homozygous patient
would miss if he was misclassified, i. e., false negative. C denotes
the cost of examining a non-diseased person. According to different
levels of expected utility, corresponding cut-off values for various



























erozygous subjects. The optimum cut-off value was 30
μτηοΐ/ΐ for serum iron and 34 μιηοΐ/ΐ for serum transfer-
rin (tab. 2).
Transfemn saturation and serum ferritin concentration
had far better discriminatory abilities. Almost complete
discrimination was obtained with these two variables,
displaying the largest area under the ROC curve. The
optimum cut-off value was 61% for transferrin satura-
tion and 800 μg/l for serum ferritin concentration
(tab. 2).
Discussion
Until specific DNA-probes which can detect the
haemochromatosis allele have been developed, the
available discriminators consist of the biochemical tests
serum transferrin saturation and serum ferritin concen-
tration. Due to the biological variation, it is often diffi-
cult to define the threshold value, by which the clinician
will be able to discriminate between normal and abnor-
mal. The ROC analysis has been developed to cope
specifically with this problem.
It appeared that both serum iron concentration and se-
rum transferrin concentration were unsuitable as
discriminators in haemochromatosis, both displaying a
high degree of misclassification. Similar results have
been reported in other studies (3, 4, 6).
Serum ferritin concentration and transferrin saturation
displayed the highest discriminatory ability, with an op-
timum calculated value for transferrin saturation of 61%.
The diagnostic potential of transferrin saturation has
been evaluated by other statistical methods (3—6). Da-
done et al. (3) examined laboratory data in pedigree
studies of haemochromatosis patients, using discrimi-
nant analysis, and found that transferrin saturation was
superior to serum ferritin concentration in predicting the
genotype. A threshold transferrin saturation value of
62% correctly predicted homozygosity in 92% of the
cases (3).
Borwein et al. (5) evaluated the diagnostic potential of
transferrin saturation alone and in combination with se-
rum ferritin concentration in pedigree studies using a
likelihood analysis model. A transferrin saturation of
55% provided the best statistical combination of true-
positive and true-negative results. A cut-off point of
55% for transferrin saturation and a cut-off point at the
90th percentile for serum ferritin concentration were
sufficient for detection of haemochromatosis, when the
results of one or both tests were positive (5).
Bassett et al. (4) assessed the value of transferrin satura-
tion and serum ferritin concentration using sensitivity,
specificity, predictive value of a positive test (PVpos) and
predictive value of a negative test (PVneg). Transferrin
saturation and serum ferritin concentration demonstrated
high levels of sensitivity and specificity. The authors
suggested a cut-off point of 55% for transferrin satura-
tion. The diagnostic efficiency was not improved if
transferrin saturation and serum ferritin concentration
were combined. However, serum ferritin concentration
appeared to be an accurate indicator of body iron over-
load (4).
In a previous report (6), the present series was analyzed
using predictive values, PVpos, PVneg, and efficiency ac-
cording to Vecchio (14). The maximum efficiency for
the four iron status markers was obtained with the
following discriminatory values: serum iron, 29 μηιοΐ/ΐ;
serum transferrin, 30 μηιοΐ/l; transferrin saturation, 60%;
serum ferritin, 800 μg/l (6). Clearly, the cut-off values
calculated by ROC analysis were similar or close to
those calculated by the Vecchio principles.
Three different statistical methods, discriminant analysis
(3), predictive analysis according to Vecchio (6) and
ROC analysis have indicated a transferrin saturation
threshold value of 60—62% as being most efficient in
the discrimination between subjects being homozygous
and heterozygous for the haemochromatosis allele.
ROC analysis gives the opportunity to adjust for the lost
benefit of false negative and cost of false positive mis-
classifications. Untreated haemochromatosis may lead to
premature death, most often due to cirrhosis of the liver
and/or hepatoma (1,2). If the genetic abnormality is rec-
ognized in the preclinical phase, overt disease can be
prevented by depletion of the iron overload through
therapeutic phlebotomy.
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Tlie disease prevalence of hereditary haemochromatosis
among Danish male blood donors is estimated to 0.37—
0.46% (15). The ultimative cost of a false negative mis-
classification may be permanent disability and prema-
ture death, whereas the cost of a false positive misclassi-
fication includes the expense of an additional serum fer-
ritin measurement and a liver biopsy.
The transferrin saturation level reflects the presence of
the haemochromatosis allele, while the serum ferritin
concentration reflects the level of iron overload. Serum
ferritin concentration per se cannot therefore be used in
the general screening procedure, as subjects with pre-
clinical haemochromatosis may have normal or only
slightly elevated concentrations. When a transferrin sat-
uration above the critical level has been identified, se-
rum ferritin concentration should be measured in order
to assess the magnitude of the iron overload, i. e., the
severity of the disease. The lowest ferritin concentration
found in homozygous subjects with clinically overt dis-
ease in this series was 800 μ§/1, while homozygous sub-
jects with preclinical disease display values ranging
from 50 to 600 μg/l (2). According to the present results,
a critical serum ferritin value of 800 μg/l seems appro-
priate to discriminate between patients with preclinical
and clinical disease.
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